Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of glaucoma using phosphodiesterase inhibitors

Treatment of glaucoma using phosphodiesterase inhibitors

US Patent 5011843 · Granted Apr 30, 1991

Estimated economic value: $59,071,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gastric retentive oral dosage form with restricted drug release in the lower gas2018
Gastric retentive oral dosage form with restricted drug release in the lower gas2011
Pharmacological inducement of the fed mode for enhanced drug administration to t2008
Extending the duration of drug release within the stomach during the fed mode2003
Extending the duration of drug release within the stomach during the fed mode2002
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingl1999
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms1996
Sustained-release oral drug dosage form1991
Treatment of glaucoma using phosphodiesterase inhibitors1990
Ocular preparation housing steroid in two different therapeutic forms1984
Topical composition containing steroid in two forms released independently from 1984
Ocular insert housing steroid in two different therapeutic forms1981